Parth Shah is an Oncology physician affiliated with Dartmouth–Hitchcock Medical Center. OpenAlex indexes 42 publications with 352 citations (h-index 8); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Medical Center Dr
Lebanon, NH 037560001
Telephone
603-508-8693Provider last certified this registry record 15 May 2021.
Clinical trials
- The PharmFIT Study
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Mi-Helper Transnasal Cooling for Acute Treatment of Migraine
Sponsor: CoolTech LLC
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20259 payments
- Legend Biotech USA Inc.Program year20251 payment
- Kite Pharma, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
77.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor77.1%Acyclovir100%Part D≥12 patientsCancer & immunology
22.9%Selective immunosuppressants22.9%Rezurock100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-16717-ACC CONDUCTION SYSTEM PACING VERSUS RIGHT VENTRICULAR PACING IN ADVANCED HEART FAILURE: RESULTS FROM A PROPENSITY-MATCHED COHORT
Journal of the American College of Cardiology
2026 - Determining Cancer Biomarker Status by RNA Sequencing
International Journal of Radiation Oncology*Biology*Physics
2025 - Abstract No. 579 Retrospective Evaluation of Carotid Artery Calcium Scores on Contrast-Enhanced CT Angiography and Its Association with Restenosis and Reintervention After TCAR or TFCAS
Journal of Vascular and Interventional Radiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Tanush Gupta, MD
Dartmouth–Hitchcock Medical Center
Jack Cronenwett, MD
Dartmouth–Hitchcock Medical Center
David Malenka, MD
Dartmouth–Hitchcock Medical Center
Robert Santulli, MD
Dartmouth–Hitchcock Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”